All non-aqueous reactions were performed under an atmosphere of nitrogen. Water-sensitive reactions were performed in oven-dried glassware, cooled under nitrogen before use, or flame-dried, and cooled, under vacuum if stated. Solvents were removed under reduced pressure using either a Büchi rotary evaporator and a Vacuubrand PC2001 Vario diaphragm pump, or a Genevac HT-4 evaporation system. Solvents were distilled before use when necessary and possible according to scale. Dichloromethane was freshly distilled from calcium hydride. Triethylamine was purified by refluxing with potassium hydroxide and potassium carbonate, followed by distillation under nitrogen, and was stored over potassium hydroxide. Ether refers to diethyl ether and petrol refers to petroleum spirit (b.p. 40-60 C). Commercially available starting materials were obtained from Sigma-Aldrich or Alfa Aesar.
pre-conditioned with 8:2 methanol-water. Crude reaction mixtures were loaded onto cartridges using either N,N,-dimethylformamide or tetrahydrofuran and eluted using 8:2 methanol-water (a fluorophobic eluent) followed by methanol (a fluorophilic solvent) using compressed air in a manner similar to that described by Curran. 2, 3 Proton and carbon NMR spectra were recorded on a Bruker Avance 500, Avance DPX300 or DRX500 spectrophotometer with an internal deuterium lock. Carbon NMR spectra were recorded with composite pulse decoupling using the waltz 16 pulse sequence. DEPT, COSY, HMQC, HMBC, TOCSY or NOESY pulse sequences were used to aid the assignment of spectra. Chemical shifts are quoted in parts per million downfield of tetramethylsilane, and coupling constants (J) are given in Hz. NMR spectra were recorded at 300 K unless otherwise stated.
Infra-red spectra were recorded using a Perkin-Elmer Spectrum One FT-IR spectrophotometer. Spectra of solids and foams were recorded using solid state golden gate probes whilst spectra of oils were performed neat on sodium chloride discs. Melting points were recorded on a Reichert hot stage microscope and are uncorrected. Nominal mass spectrometry was routinely performed on a Waters-Micromass ZMD spectrometer using electrospray (+) ionization. Nominal and accurate mass spectrometry using electrospray ionisation was carried out by staff in the School of Chemistry using either a Micromass LCT-KA111 or Bruker MicroTOF mass spectrometer. Field Desorption ionisation mass spectra were acquired on a WatersMicromass GCT premier spectrometer equipped with a Linden LIFDI probe. Optical activity measurements were recorded at room temperature unless otherwise stated; units for [] D are 10 -1 deg cm 2 g -1 and are omitted. + ).
(1R*, 2S*, 3R*, 4S*)-2-Acetoxymethyl-3-hydroxymethyl-7-oxabicyclo[2.2.1]hept-5-ene

O OAc OH
Acetic anhydride (1.3 mL, 12.8 mmol) was added to a stirred solution of (1R*,2S*,3R*,4S*)- (3-hydroxymethyl-7-oxa-bicyclo[2.2.1] hept-5-en-2-yl)-methanol 5 (200 mg, 1.28 mmol) and cerium chloride (47.6 mg, 0.13 mmol) in tetrahydrofuran (4 mL). The reaction mixture was stirred at room temperature for 16 hours, diluted with ethyl acetate (20 mL) and washed with saturated aqueous sodium bicarbonate solution (2 × 10 mL). The combined organic extracts were dried (MgSO 4 ) and concentrated in vacuo to give a crude product which was purified by flash chromatography, eluting with 1:1 petrol-EtOAc, to give (1R*, 2S*, 3R*, 4S*) -2-acetoxymethyl-3-hydroxymethyl-7- 6.49 (1H, dd, J 5.9 and 2.1, 6-H), 6.45 (1H, dd, J 5.9 and 2.1, 5-H), 5.05-5.01 (1H, m, 1-H), 4.99-4.94 (1H, m, 4-H) , 3.98 (1H, app dd, J 11.3 and 5.9 , 2-CH A ), 3.67 (1H, app. dd, J 10.8 and 9.2, 3- 
.1]hept-5-ene
Silver oxide (2.62 g, 11. 3 mmol, 2 eq.) was added to a stirred solution of (1R*, 2S*, 3R*, 4S*)-2-acetoxymethyl-3-hydroxymethyl-7-oxabicyclo[2.2.1]hept-5-ene (1.12 g, 5. 65 mmol) in allyl bromide (20 mL) and the suspension was stirred in the dark for 3 days. The reaction mixture was filtered through Celite, washing with EtOAc, and the filtrate was concentrated under reduced pressure to give a crude product which was purified by flash chromatography, eluting with 85:15 petrol-EtOAc, to give (1R*,2S*,3R*,4S*)-2-acetoxymethyl-3-allyloxymethyl-7-oxa-bicyclo[2.2.1]hept-5-ene (714 mg, 53%) as a colourless oil, R f 0.43 (7:3 petrol-EtOAc);  max /cm -1 3079, 3000, 2937, 2863, 1732, 1645, 1428, 1367, 1238 3, 136.0, 135.2, 134.9, 117.7, 81.0, 80.7, 72.6, 69.1, 63.9, 41.3, 39.9 and 21.3 3.94 (1H, app ddt, J 14.1, 5.8 and 1.5, allyl 3-H b ), 3.45-3.39 (1H, m, 3- CCH a ), 3.35 (1H, dd, J 9.4 and 6.0, 3.31 (1H, dd, J 11.1 and 9.4, 3.15 (1H, t, J 9.4, OH), m, 2.73 (1H, ddt, J 9.8, 5.6 and 4.5, ddt, J 9.4, 5.3 and 4.5, [2] [3] [4] [5] [6] [7] H);  C (75 MHz, CDCl 3 ) 135.5 (5-C), 135.2 (6-C), 134.1 (allyl 2-C), 118.5 (allyl 3-C), 80. Sodium hydride (120 mg of a 60% dispersion in mineral oil, 2.99 mmol, 1.1 eq.) was added to a stirred solution of (1R*, 5S*) -1,5-bis-hydroxymethyl-8-oxa-bicyclo[3.2.1]oct-6-en-3-one (500 mg, 2.71 mmol) in N,N-dimethylformamide (6 mL) at 0 C, the reaction mixture allowed to warm to room temperature and stirred for 30 mins. The reaction mixture was cooled to 0 C, allyl bromide (282 L, 3.26 mmol, 1.2 eq.) added dropwise and the reaction mixture allowed to warm to room temperature and stirred for 22 h. The reaction mixture was cooled to 0 C, quenched with saturated aqueous ammonium chloride solution (6 mL), diluted with ether (60 mL), aqueous separated, organics washed with brine (4  30 mL) and water (30 mL).
The combined aqueous fractions were extracted with ethyl acetate (100 mL), washed with brine (50 mL), organics combined, dried (MgSO 4 ) and concentrated under reduced pressure. The residue was purified by flash chromatography (gradient elution: 9:18:27:36:41:1 petrol-EtOAc) to give (1R*,5S*) -1-allyloxymethyl-5-hydroxymethyl-8-oxa-bicyclo[3.2.1] oct-6-en-3-one (137 mg, 23%) as a pale yellow oil, R f 0.17 (1:1 petrol-EtOAc);  max /cm -1 3445, 3082, 3010, 2919, 2862, 1714, 1643, 1454, 1343, 1282, 1152 and 1056 ;  H (500 MHz, CDCl 3 ) 6.16 (1H, d, J 6.5, 6-H), 6.15 (1H, d, J 6.5, 7-H), 5.95 (1H, ddd, J 17.3, 10.4 and 5.8, allyl 2-H), 5.34 (1H, dd, J 17.3 and 1.5, allyl 3-H a ), 5.27 (1H, dd, J 10.4 and 1.5, allyl 3-H b 3.85 (1H, d, J 12.3, 3.74 (1H, d, J 10.4, 3.70 (1H, d, J 10.4, Silver oxide (4.58 g, 19 .76 mmol, 2 eq.), was added to a rapidly stirred suspension of (1R,4S)-4-hydroxycyclohept-2-enyl acetate 7 (1.68 g, 9.88 mmol, 1 eq.), and 4 Å molecular sieves (500 mg) in allyl bromide (40 mL). The contents of the flask were protected from the light and the progress monitored by TLC. After 36 hours the reaction was complete. The suspension was filtered through celite and washed with EtOAc (3  50 mL). The organic filtrate was washed with brine (2  30 mL) and dried over magnesium sulfate.
Concentration under reduced pressure gave a residue which was purified by flash chromatography, eluting with 8:2 petrolEtOAc to afford (1R,4S)-4-(allyloxy)cyclohept-2-enyl acetate (1.30 g, 6.20 Sodium methoxide (33 mg, 0.62 mmo, 0.1 eq.), was added to a solution of (1R,4S)-4-(allyloxy)cyclohept-2-enyl acetate (1.30 g, 6.2 mmo, 1 eq.), in MeOH (50 mL), and the progress of the reaction monitored by TLC.
After 24 hrs the reaction was concentrated under reduced pressure to afford a residue that was purified using flash chromatography, eluting with 8:2 petrolEtOAc, to give (1R,4S)-4-(allyloxy)cyclohept-2-enol (880 mg, 2, 135.1, 134.5, 117.4, 78.1, 71.4, 69.9, 36.2, 32.6 and 23.6 . An ionisation technique was not found which identified the required mass ion. 2 
Synthesis of diisopropylsilyl ethers
O O Si (i-Pr)
H (4-(Allyloxy)but-2-ynyloxy)diisopropylsilane 13a
By general procedure C, 4-(allyloxy)but-2-yn-1-ol 8 (422 mg, 3.34 mmol) gave a crude product after 15 mins.
The crude silyl ether 13a (743 mg, 93%) was obtained as a pale yellow oil which was used without furher purification, R f 0.83 (8:2 petrol-EtOAc);  max /cm -1 3082, 2944, 2893, 2865, 2097, 2236, 1463, 1366, 1352, 1262, 1245, 1128, 1086, 1065 
(Pent-4-enyloxy)diisopropylsilane 13b
By general procedure C, pent-4-en-1-ol (1.00 g, 11.6 mmol) gave a crude product after 30 mins. The crude silyl ether 13b (2.27 g, >98%) was obtained as a pale yellow oil which was used without further purification, R f 0.92 (9:1 petrol-EtOAc);  max /cm -1 3079, 2942, 2894, 2866, 2090, 1642, 1463, 1385, 1100, 1066 
[1-(2',4'-Dimethoxy-phenyl)-allyloxy]-diisopropyl-silane 13d
By general procedure C, 1-(2,4-dimethoxyphenyl)prop-2-en-1-ol 9 (300 mg, 1.54 mmol) gave a crude product after 1 h. The crude silyl ether 13d (473 mg, >98%) was obtained as a colourless oil which was used without further purification, R f 0.78 3000, 2943, 2890, 2865, 2097, 1613, 1590, 1504, 1463, 1290, 1256, 1208, 1157 9, 128.0, 124.6, 104.7, 98.5, 55.7 (OMe), 17.9, 17.8, 17.7, 17.5, 12.9, 12.8 ( i 
(R)-Diisopropyl-(1-phenyl-allyloxy)-silane (-)-13e
By general procedure C, (R)-1-phenylprop-2-en-1-ol (479 mg, 3.57 mmol) gave a crude product after 20
mins. The crude silyl ether 13e (821 mg, 93%) was obtained as a colourless oil which was used without purification, R f 0.86 ( MHz, CDCl 3 ) 143.6 (ipso-Ph), 141.4 (2-C), 128.6 (Ph), 127.6 (para-Ph), 126.6 (Ph), 114.4 (3-C), 78. 
Diisopropyl(1-phenylbut-3-enyloxy)silane 13f
By general procedure C, 1-phenylbut-3-en-1-ol (224 mg, 1.51 mmol) gave a crude product after 15 mins.
The crude silyl ether 13f (421 mg, >98%) was obtained as a pale yellow oil which was used without further purification, R f 0.89 (9:1 petrol-EtOAc);  max /cm -1 3078, 3030, 2943, 2893, 2865, 2096, 1641, 1493, 1462, 1365, 1243, 1087, 1063 
(+)-(2S)-diisopropyl(pent-4-en-2-yloxy)silane 13g
By general procedure C, (S)-pent-4-en-2-ol (258 mg, 3.0 mmol) gave a crude product after 40 mins. The crude silyl ether 13g (221 mg, 37%) was obtained as a colourless oil and was used without further purification, R f 0.69 (8:2 petrol-EtOAc); [] D + 3.6 (c 1.0 in CHCl 3 );  max /cm -1 3079, 2943, 2894, 2866, 2093, 1642, 1463, 1377, 1242, 1128, 1089, 1057, 1045 2940, 2893, 2865, 2093, 1647, 1463, 1425, 1391, 1366, 1300, 1243, 1254, 1083, 1061 By general procedure D, the alcohol 11 6 (60 mg, 79 mol), the silyl ether 13a (3.5 eq.), N-bromosuccinimide (3 eq.) at 0.1 M 6 gave a cude product after 30 mins. 
N-(2-{4-[(pen-4-enyloxy)-diisopropyl-silanyloxy]-but-2-enyloxymethyl}-allyl)-N-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-decyl)-4''''-methylbenzenesulfonamide 7b
By general procedure D, the alcohol 11 6 (200 mg, 0.264 mmol), the silyl ether 13b (3.5 eq.), Nbromosuccinimide (3 eq.) at 0.1 M 6 gave a cude product after 14 h. The crude product was purified by 
N-(2-{4-[(hex-5-enyloxy)-diisopropyl-silanyloxy]-but-2-enyloxymethyl}-allyl)-N-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-decyl)-4''''-methylbenzenesulfonamide 7c
By general procedure D, the alcohol 11 6 (150 mg, 0.198 mmol), the silyl ether 13c (3.5 eq.), Nbromosuccinimide (3 eq.) and N,N-dimethylaminopyridine (0.1 eq.) gave a crude product after 12 h. The crude product was purified by Fluorous-Solid Phase Extraction (2 g cartridge, loading with ≤ 400 L DMF)
to give the silaketal 7c (179 mg, 93%, 88% purity) as a colourless oil, R f 0.87 (7:3 petrol-EtOAc),  max /cm -1 3079, 3027, 2944, 2869, 1657, 1641, 1599, 1495, 1463, 1350, 1242, 1212, 1163, 1089 By general procedure D, the alcohol 11 6 (150 mg, 0.198 mmol) , the silyl ether 13d (3.5 eq.) , Nbromosuccinimide (3 eq.) and N,N-dimethylaminopyridine (0.1 eq.) gave a crude product after 12 h. The 17 crude product was purified by Fluorous-Solid Phase Extraction (2 g cartridge, loading with ≤ 400 L DMF).
The organic fraction was filtered through a short pad of Florisil, eluting with 9:1 petrol-EtOAc, to give the silaketal 7d (47 mg, 56%) as a colourless oil, R f 0.53 (8:2 petrol-EtOAc);  max /cm -1 3082, 2945, 2868, 1640, 1614, 1588, 1504, 1463, 1352, 1330, 1289, 1242 (1-C), 40. 3, 143.9, 141.8, 141.1, 136.1, 132.8, 130.3, 128.7, 128.6, 127.6, 127.5, 126.9, 126.8, 18 126. 4, 117.1, 113.7, 75.9, 70.8, 66.7, 59.6, 52.0, 40.8, 31.0, 21.9, 17.7, 17.6, 17.5 and 12.7; m/ By general procedure D, the alcohol 11 6 (168 mg, 0.22 mmol), the silyl ether 13f (5.5 eq.), Nbromosuccinimide (5 eq.) and N,N-dimethylaminopyridine (0.5 eq.) in dichloromethane (0.1 M) gave a crude product after 14 h. The crude product was purified by Fluorous-Solid Phase Extraction (5 g cartridge, loading with ≤ 1 mL DMF) to give the silaketal 7f (222 mg, >98%, 76% purity), R f 0.86 (8:2 petrol-EtOAc);
 max /cm -1 3061, 3018, 2947, 2935, 2858, 1655, 1590, 1465, 1357, 1245, 1201, 1165 9, 144.3, 141.1, 136.2, 135.0, 132.9, 130.3, 128.4, 127.7, 127.5, 126.8, 126.5, 117.5, 117.0, 74.9, 70.8, 66.7, 59.6, 51.9, 45.6, 40.8, 31.1, 21.9, 17.8, 17.7, 17.6, 17.5, 17.4 and 12.7; m/z (ES+) By general procedure D, the alcohol 11 6 (150 mg, 0.198 mmol) , the silyl ether 13e (3.5 eq.) , Nbromosuccinimide (3 eq.) and N,N-dimethylaminopyridine (0.1 eq.) gave a crude product after 12 h. The crude product was purified by Fluorous-Solid Phase Extraction (2 g cartridge, loading with ≤ 400 L DMF)
to give the silaketal 7e (182 mg, 96%, 85% purity), R f 0.86 (7:3 petrol-EtOAc);  max /cm -1 3078, 3027, 2945, 19 2869, 1642, 1599, 1463, 1396, 1351, 1243, 1209, 1089 and 1059 By general procedure D, the alcohol 11 6 (318 mg, 0.42 mmol), the silyl ether 13h (3.5 eq.) , Nbromosuccinimide (3 eq.) and N,N-dimethylaminopyridine (0.1 eq.) gave a crude product after 14 h. The crude product was purified by Fluorous-Solid Phase Extraction (5 g cartridge, loading with ≤ 1 mL DMF) and the fluorous fraction was filtered through a pad of Florisil eluting with 9:1 petrol-EtOAc to give the silaketal 7h (244 mg, 54%) as a colourless oil, R f 0.73 (7:3 petrol-EtOAc);  max /cm -1 3081, 2945 , 2868 , 1657 , 1599 , 1463 , 1349 , 1242 , 1207 , 1155 , 1116 and 1061  H (500 MHz, CDCl 3 ) 7.73 (2H, d, J 8.5, 2-H), 7.36 (2H, d, J 8.5, 3-H), 6.39 (1H, d, J 7.4, 5-H), 6.38 (1H, d, J 7.4, 6-H), 5.95 (1H, ddd, J 17.2, 10.4 and 5.4, allyl 2-H), 5.75 (1H, dt, J 11.3 and 5.8, 3-H), 5.61 (1H, dt, J 11.3 and 6.2, 2-H), 5.30 (1H, dd, J 17.2 and 1.4, allyl 3-H a ), 5.29 (1H, s, 3-H a ), 5.21 (1H, br d, J 10.4, allyl 3-H b ), 5.15 (1H, s, 3-H b ), 4.93 (1H, s, 4-H), 4.87 (1H, s, 1-H), 4.38 (2H, d, J 5.8, 4-H), 4.07 (2H, d, J 6.2, 1-H), 4.01 (2H, d, J 5.4, allyl 1-H), 3.94-3.91 (3H, m, 2-CCH 2 O and 2-CCH a ), 3.81 (2H, s, 3.67 (1H, app t, J 9.8, 3.59 (1H, dd, J 8.9 and 5.5, m, ), 2.47 (3H, s, 4-CCH 3 ), 2.44-2.40 (2H, m, 2-H), 1.92 (1H, ddd, J 8.9, 8.5 and 5.5, 3-H), 1.89 (1H, ddd, J 9.8, 8.5 and 5.6, 2-H) By general procedure D, the alcohol 11 6 (76 mg, 0.10 mmol), the silyl ether 13i (3.5 eq.) , Nbromosuccinimide (3 eq.) and N,N-dimethylaminopyridine (0.1 eq.) gave a crude product after 14 h. The crude product was purified by Fluorous-Solid Phase Extraction (5 g cartridge, loading with ≤ 1 mL DMF) and the fluorous fraction was filtered through a pad of Florisil eluting with 9:1 petrol-EtOAc to give the silaketal 7i (63 mg, 59%) as a colourless oil, R f 0.50 (7:3 petrol-EtOAc);  max /cm -1 3081, 3010, 2945 , 2862 , 1651 , 1599 , 1492 , 1465 , 1455 , 1401 , 1347 , 1336 and 1242  H (500 MHz, CDCl 3 ) 7.72 (2H, d, J 8.2, 2-H), 7.34 (2H, d, J 8.2, 3-H), 6.48 (1H, dd, J 5.9 and 1.4, 6-H), 6.44 (1H, dd, J 5.9 and 1.4, 5-H), 5.89 (1H, dddd, J 17.3, 10.4, 5.6 and 4.1, allyl 2-H), 5.73 (1H, dt, J 11.3 and 5.8, 3-H), 5.62 (1H, dt, J 11.3 and 6.1, 2-H), 5.89 (1H, dddd, J 17.3, 10.4, 5.6 and 4.1, allyl 2-H), 5.73 (1H, dt, J 11.3 and 5.8, 3-H), 5.62 (1H, dt, J 11.3 and 6.1, 2-H), 5.30 (1H, s, 3-H a ), 5.27 (1H, app dq, J 17.3 and 1.5, allyl 3-H a ), 5.20 (1H, app dq, J 10.4 and 1.4, allyl 3-H b ), 5.16 (1H, s, 3-H b ), 5.02 (1H, br d, J 3.1, 1-H), 5.01 (1H, br d, J 3.3, 4-H), 4.37 (2H, d, J 5.8, 4-H), 4.07 (2H, d, J 6.1, 1-H), 3.96 (2H, s, 2-CCH 2 O), 3.92 (1H, br dd, J 12.9 and 4.1, allyl 1-H a ), 3.90 (1H, br dd, J 12.9 and 5.7, allyl 1-H b ), 3.81 (2H, s, 1-H), 3.70 (1H, dd, J 9.9 and 5.6, 2-CCH a N-(2-{(Z)-4-[(-5-Allyloxymethyl-3-oxo-8-oxa-bicyclo[3.2.1]oct-6-en-1-ylmethoxy)-diisopropyl-silanyloxy]-but-2-enyloxymethyl}-allyl)-N-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-decyl)-4-methyl- 
benzenesulfonamide 7j
By general procedure D, the alcohol 11 6 (73 mg, 0.096 mmol), the silyl ether 13j (3.5 eq.) , Nbromosuccinimide (3 eq.) and N,N-dimethylaminopyridine (0.1 eq.) gave a crude product after 14 h. The crude product purified by Fluorous-Solid Phase Extraction (2 g cartridge, loading with ≤ 400 L DMF). The fluorous fraction was filtered through a pad of Florisil eluting with 9:1 petrol-EtOAc to give the silaketal 7j
(34 mg, 32%) as a colourless oil, R f 0.79 (7:3 petrol-EtOAc);  max /cm -1 3082, 3021, 2927, 2862, 1715, 1657, 1599, 1495, 1463, 1451, 1401, 1344, 1243, 1212, 1160 By general procedure D, the alcohol 11 6 (81 mg, 0.108 mmol), the silyl ether 13k (3.5 eq.) , Nbromosuccinimide (3 eq.) and N,N-dimethylaminopyridine (0.1 eq.) in dichloromethane (0.2 M) gave a crude 22 product after 2 h. The crude product was purified by Fluorous-Solid Phase Extraction (2 g cartridge, loading
with ≤ 400 L DMF) and the fluorous fraction filtered through a short pad of Florisil eluting with 9:1 petrolEtOAc to give the silaketal 7k (70 mg, 64%) as a colourless oil, R f 0.63 (8:2 petrol-EtOAc);  max /cm -1 3060, 2945, 2895, 2868, 1598, 1464, 1363, 1350, 1242, 1213, 1163, 1088 
heptadecafluoro-decyl)-4-methyl-benzenesulfonamide (+)-7l
By general procedure D, the alcohol 11 6 (43 mg, 0.057 mmol), the silyl ether 13l (3.5 eq.) , Nbromosuccinimide (3 eq.) and N,N-dimethylaminopyridine (0.3 eq.) in dichloromethane (0.1 M) gave a crude product after 12 h. The crude product was purified by Flurous-Solid Phase Extraction (2 g cartridge, loading
with ≤ 400 L DMF) to give the silaketal 7l (56 mg, 95%, >80% purity as estimated using 500 MHz 1 H NMR spectroscopy) as a colourless oil, R f 0.43 (9:1 petrol-EtOAc), [] D +3.6 (c 1.0 in CHCl 3 );  max /cm -1 3076, 3027, 2929, 2868, 1656, 1599, 1495, 1463, 1393, 1351, 1242, 1212, 1157, 1061 m, 5-H a ), 1.84-1.81 (1H, m, 7-H a ), 1.68-1.58 (2H, m, 6-H b and 7-H b ), 1.46 (1H, app q, J 12.5, 5-H b 3, 141.1, 137.9, 136.2, 135.3, 133.8, 132.8, 130.3, 127.6, 127.1, 117.1, 117.0, 79.2, 72.6, 70.9, 69.8, 66.8, 59.6, 52.0, 40.8, 36.9, 32.8, 31.1, 30.1, 25.1, 21.9, 17.7, 17.6, 17.5 and 12.6; m/z (ES+) By general procedure E, the silaketal 7j (85 mg, 0.0668 mmol) and 8 (2  3 mol%) gave a crude product after 7 h. The crude product was purified by Fluorous-Solid Phase Extraction (2 g cartridge, loading with ≤ 200 L THF) and the organic fraction was subjected to general procedure F and gave a crude product after 1 h. The crude product was purified by preparative HPLC to give the diol 17 (8.9 mg, 35%; E:Z 55:45) as a colourless film, R f 0.64 (8:2 CHCl 3 -MeOH);  max /cm -1 3399, 3076, 3016, 2921, 2857, 1712, 1596, 1456, 1407, 1366, 1333, 1249, 1226, 1091, 1061 
Synthesis of metathesis products
